International Rett Syndrome Foundation: Grant Programs LOI

-Basic Research Program wishes to promote the understanding of MeCP2 in the pathogenesis of the neurobehavioral phenotype of Rett syndrome (RTT). We seek to gain a better understanding of the underlying pathology of the disorder leading to an amelioration of the symptoms and a cure for RTT. Funding: up to $100K over 2 years.

http://www.rettsyndrome.org/research-programs/grant-programs/basic-program

-Mentored Training Fellowship Program supports scientists early in their career in both basic and clinical research in the field of Rett syndrome so that they become successful, independent basic research scientists and clinical investigators. These talented researchers will be the future leaders in the Basic, Translational and Clinical research areas for Rett syndrome. Funding: $100K over 2 years.

http://www.rettsyndrome.org/research-programs/grant-programs/mentored-training-fellowship-program

-Translational Research Program provides HeART (Help Accelerate RTT Therapeutics) and ANGEL (Advanced Neurotherapeutic Grant of Excellence) grant awards to promote the development and testing of therapeutics to treat and reverse Rett syndrome (RTT) and its symptoms. These award mechanisms seek to facilitate the development and testing of novel therapeutics targeting the underlying pathology of the disorder, thereby leading to an amelioration of symptoms or ultimately a pharmacological reversal of RTT. Through these awards, IRSF seeks to foster academic and public-private partnerships and further facilitate drug discovery, development and testing. Funding: HeART grant awards is up to $150K for 2 years; ANGEL grant awards is up to $300K per year for up to 2 years.